<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246620/" ref="ordinalpos=453&amp;ncbi_uid=6891248&amp;link_uid=PMC4246620" image-link="/pmc/articles/PMC4246620/figure/f3-ol-09-01-0235/" class="imagepopup">Figure 3.  From: The expression of Wnt-1 inducible <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> protein-2 in astrocytoma: Correlation between pathological grade and clinical outcome. </a></div><br /><div class="p4l_captionBody">Expression levels of WISP-2 were found to significantly correlate with the survival of astrocytoma patients. Kaplan-Meier estimates of progression-free survival and overall survival are shown according to expression levels of WISP-2 for 154 astrocytomas patients. P-values were obtained using the log-rank test. WISP-2, Wnt-1 inducible signaling pathway protein-2.</div></div>